11ß-HSD1 and Metabolic Syndrome

计划入组 24 人 · 首次发布于 2006 年 8 月 31 日

Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition

计划入组 32 人 · 首次发布于 2017 年 4 月 13 日

28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

计划入组 43 人 · 首次发布于 2017 年 10 月 2 日

Digestive Enzyme

Rx

11beta-HSD1 inhibitors (Galderma)

11b-HSD1 program (Cloud Pharmaceuticals)

AMANO ENZYME INC.

Japan

Lixte Biotechnology

United States

Acurx Pharmaceuticals

United States

GIP Reduces Free Fatty Acids via 11β-HSD1 Inhibition in Adipose Tissue

Actinogen's Xanamem (Emestedastat) Receives WHO Recognition and Advances in Alzheimer's Trials

Actinogen Optimizes XanaMIA Phase 2b Alzheimer's Disease Trial Design